The Utility of Circulating Tumour Cells and Plasma microRNA Detection to Predict the Response to Treatment in Patients With Esophageal Adenocarcinoma
Circulating microRNA (circ miRNA) and circulating tumour cell (CTC) levels are hypothesized
to be associated with response to chemoradiation in patients undergoing treatment for
locally advanced esophageal adenocarcinoma.
The goal of this project is to assess the use of circulating microRNA (miRNA) and
circulating tumour cells (CTC) as biomarkers of cancer and predictive markers for
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society